Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Nov 2, 2012

NEW YORK (GenomeWeb News) – BioFire Diagnostics has appointed Robert Lollini as CFO.

Lollini most recently served as CEO, and formerly as CFO of Myrexis, a Utah-based biotechnology company. He remains a member of its board of directors. From 1993 to 2007, Lollini held multiple executive positions at drug-delivery company Iomed, which was acquired in May 2007. Earlier in his career, he held various executive management positions at RP Scherer.


The Miller School of Medicine at the University of Miami said this week that Louis "Skip" Elsas, who was the first director of the John T. Macdonald Foundation Center for Medical Genetics, has died at the age of 75.

Elsas, who joined the University of Miami in 2002 and was chair of Biochemistry and Molecular Biology at the Miller School, began working in medical genetics in the 1960s.

He built a genetics program at Emory University and he was past president and chair of several national committees focused on genetics, including the National Institutes of Health's Genes, Genomes, and Genetics Integrated Review Group, and he was founding president of the Society for Inherited Metabolic Disorders.

Elsas also was a professor of pediatrics, human genetics, biochemistry, and molecular biology, and he worked to expand newborn screening programs in Florida.


Bayer CropScience has appointed Liam Condon to be chairman of its executive committee and chairman of its board of management. He will assume the posts on Dec. 1, succeeding Sandra Peterson, who will leave the company on Nov. 30.

Condon has been managing director of Bayer Vital and head of Bayer Pharma's business in Germany since 2010.

He also has served as managing director of Bayer HealthCare China and Bayer Pharma's GM for China, and he was a managing director for Schering China and a marketing and medical director at Schering for the Asia-Pacific and Middle East regions.


Empire Genomics said this week that it has hired Theresa Brown as clinical lab director, where she will head the firm's new clinical lab at the Buffalo Niagara Medical Campus.

Brown has spent the past decade as director of cytogenetic reference labs at IMPATH, Genzyme Genetics, and CSI Laboratories, and her area of expertise is in cytogenetics of leukemias and lymphomas, with experience in establishing and growing new clinical labs.


Irish molecular diagnostics company HiberGene Diagnostics said this week that it has named Tony Hill to be its CEO.

Hill joins the firm from Innogenetics, where he was global sales director. He previously was VP at OraSure Technologies and he held a number of positions at Sigma Aldrich.

The company, which is developing tools for diagnosing infectious diseases, is based at NovaUCD, the Centre for New Ventures and Entrepreneurs at University College Dublin.


Amarantus Biosciences has appointed Clinton Allen to its advisory board.

Allen previously held a number of senior positions at Bristol Myers Squibb including senior director of corporate compliance, director of risk management, director of product development and commercialization, and director of in-licensing and business development.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.